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Dr Roderick Macarthur (Edmonton, Alberta). I thank the associ-
ation for the opportunity to discuss this article, and congratulations
to Dr Patel and colleagues for an excellent and provocative article
addressing the management of patients with acute type A aortic dis-
section presenting with severe coexisting malperfusion. We are re-
minded by this article of the challenges in dealing with this high-
risk group of patients. The Michigan group’s approach to this cohort
of patients has been consistent with primary percutaneous fenestra-
tion followed by delayed central aortic repair once patients have sta-
bilized and their end-organ ischemic injury has resolved. This
strategy originated from a poor outcome with primary central aortic
repair in this group of patients.
I think this is an important article in that it provides follow-up to
a controversial article the authors published almost a decade ago.
The authors should be commended for providing an updated report
regarding the outcomes associated with their approach to these pa-
tients. Many times, controversial approaches are introduced in the
literature but never followed up with the appropriate studies. This
makes it difficult to know which approach has been proven effica-
cious in the long run and which has not. The authors are also clear
that the purpose of the article is not to compare immediate central
repair with delayed surgery but to evaluate the long-term outcomes
when their delayed approach is used. The delayed approach has sig-
nificantly improved the outcomes in their institution for this high-
risk group of patients, and they should be congratulated.
I do believe, however, that this article challenges what many of
us currently teach our trainees, that many of these malperfusion syn-
dromes will resolve with primary central aortic repair and acute type
A aortic dissection is a surgical emergency that requires immediate
surgical repair.
I have 4 questions for Dr Patel. Clearly it is in the group of pa-
tients with severe malperfusion that this strategy is used in your in-
stitution. How do you define severe malperfusion? For example, areThe Journal of Thorapatients with paraplegia delayed for surgical repair? How do you de-
fine renal malperfusion? What are the determinants that indicate that
it is now appropriate to proceed with surgical repair and that the pa-
tient has been sufficiently delayed?
Dr Patel. Typically when a patient presents at the University of
Michigan with acute type A aortic dissection, our algorithm in-
volves precisely what I mentioned. Those patients who present
with tamponade or coronary malperfusion without evidence of
a dead ventricle (eg, regardless of malperfusion) will proceed di-
rectly to operation. If patients present with severe malperfusion
with end-organ dysfunction, for example, those with significantly
abnormal or increasing creatinine, severe abdominal pain, abnormal
abdominal exam, or neurologic malperfusion with dense stroke or
paraplegia, their operative procedure will be delayed until their
ischemia reperfusion injury resolves. This would be evident by de-
creasing creatinine, restoration of urine output, or benign abdominal
exam. It is important to note that a specific objective number is not
targeted for us to decide on the date of operation, but rather the entire
clinical picture is used to determine the optimal time of aortic repair.
Dr Macarthur. Many advances in the management of these
complex cases have taken place during the past years. For example,
some believe that antegrade perfusion from the outset with right ax-
illary cannulation is beneficial, particularly in patients with malper-
fusion. Do you believe that strategies and other such advances will
affect the outcome in this high-risk group of patients? Do you antic-
ipate this influencing the management of your delayed strategy?
Dr Patel. I am not sure how axillary perfusion would alter per-
fusion to the end organs because the path of blood flow often will be
similar to that seen with restoring perfusion in an antegrade fashion.
DrMacarthur. How often did the percutaneous interventions in
the malperfusion group successfully reestablish flow within a com-
promised branch vessel, and were there any direct complications
from this procedure, for example, in the 23 patients who died while
awaiting surgical repair, were any of those deaths due to complica-
tions from the fenestration procedure?
Dr Patel. We are very fortunate. We have a good interventional
radiology team that we work closely with, and thankfully none of the
complications, none of the mortality that was seen in those patients
who were awaiting resolution of the malperfusion syndrome, were
attributed directly to the results of the fenestration procedure.
Dr Macarthur. My final question is, have the authors consid-
ered the thoracoabdominal aorta in this group of patients and does
a delayed approach influence a requirement for the risk and need
for subsequent distal surgery? What is your follow-up imaging strat-
egy in these patients and does it differ from patients presenting with-
out malperfusion?
Dr Patel. Typically the thoracoabdominal aorta is dissected in
these patients who present with malperfusion. Our approach of cre-
ating a flap fenestration may prevent total thrombosis of the residual
dissected aorta by creating a large reentry tear, but that is uncertain
and is a subject of future study. Our followup in all patients following
repair of acute Type A dissection, whether malperfusion existed or
not is the same. We image them with echocardiography and CT scan-
ning only (3 and 9 months) and then annually thereafter if the aorta
remains stable. Our indications for intervening on the distal dissected
aorta are the standard ones, namely size, growth or symptoms.
Dr Craig Miller (Stanford, Calif). Thank you for updating the
Michigan series. I will never forget in January 1996 when Mikecic and Cardiovascular Surgery c Volume 135, Number 6 1295
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took a lot of flack.
Dr Patel. He still has some bullet holes I think. [laughter]
DrMiller. It is good to see the follow-up. I am not sure, however,
exactly what you have learned from the last 10 years; perhaps the
most salient question I need to ask is how many patients did you ac-
tively decide to do nothing for because of irreversible infarction of the
gut, kidney, brain, or some other important end organ? Are you still in
the ‘‘warm autopsy’’ mode that Mike was accused of 11 years ago?
Dr Patel.Of the 23 patients who died, 11 expired directly as a re-
sult of malperfusion syndrome with multisystem organ failure. Half
of these had dense neurologic deficits and never recovered. The re-
maining 12 patients ruptured while awaiting resolution of their mal-
perfusion syndrome. In this group, evidence of severe ischemia
reperfusion injury was still apparent, and included for example, pa-
tients who required laparotomy for bowel resection.
Dr Chad Hughes (Durham, NC). I have a couple questions for
you. Maybe I just missed it, but did you break down the difference—
I mean, I think dynamic malperfusion of the gut and static malper-
fusion of the gut are 2 different animals. If someone presents acutely
with acute type A dissection, with some abdominal pain and evi-
dence of dynamic malperfusion on CT scan, that should get better
by replacing the ascending aorta, but if it is static malperfusion
and the superior mesenteric artery is thrombosed, that is obviously
not going to get better by reestablishing true lumen flow. In our ex-
perience, that has a much higher mortality rate, and those are the pa-
tients in whom we will typically place branched vessel grafts into the
superior mesenteric artery or celiac first before we do the ascending
aorta, versus if it is just dynamic malperfusion, we would expect that
to get better by replacing the ascending aorta. Have you looked at the
difference between those?
Dr Patel. We have not. It is an interesting point, but the intention
of this analysis was to look at the outcomes on an intent-to-treat basis.
You cannot always sort out the dynamic vs. static mechanism on the
preoperative CT scan. We agree that dynamic obstruction will re-
solve with central aortic repair. However, in the group treated with1296 The Journal of Thoracic and Cardiovascular Surgery c Junoperative delay in this presentation were those that had evidence of
significant end-organ ischemia with dysfunction. I think that was
the biggest point that Mike had tried to make in the original presen-
tation, namely that a difference exists between end-organ ischemia
and end-organ ischemia with severe end-organ dysfunction. It was
the our intent to focus on that latter group in both the first and the
current study.
Dr Hughes. I think it depends on how early they present. My
second question is on fenestrations. Have you tried, which we
have done, just using endografts instead only in the true lumen?
We have had, at least in our institution, better success with that com-
pared with fenestration, especially for dynamic malperfusion, to
open the true lumen.
In your delayed group, are any of the deaths due to rupture of the
aorta or severe aortic insufficiency with heart failure rather than mal-
perfusion syndrome?
Dr Patel. I am not sure that treating a dissected thoracobdominal
aorta with a thoracic endograft is the best therapy. I think that one of
the biggest issues is that in this situation, both the proximal and dis-
tal landing zones are not necessarily stable since the aorta is not nor-
mal. Secondly, you would be covering up multiple intercostals, and
thus subjecting patients to a risk for paralysis. When we perform per-
cutaneous fenestration and stenting, it is a percutaneous procedure
maintaining intercostal artery patency and avoiding the need to de-
liver larger bore devices through a femoral cutdown.
Regarding the second question concerning cardiac causes of
death, it is important to note that in contrast to the original study
where there were patients with severe ventricular dysfunction and
coronary malperfusion, for some reason in this study no patients
with this scenario were seen during the current study period. If pa-
tients had severe aortic insufficiency and had severe ischemic end-
organ dysfunction, operative delay was utilized in some. However,
if they did not appear to be tolerating the AI, we proceeded to oper-
ative repair earlier. Again, what is important to note is that the clin-
ical decision to proceed with surgery was undertaken after
evaluating the entire clinical scenario.e 2008
